Regeneron Pharmaceuticals Inc.
REGN | NASDAQ
$967.64
+$39.75 (+4.28%)
Nov 2, 2026, 1:20 PM ET · Market open
Fiscal Quarter Period Ending | Q3 2026 Sep 30, 2026 | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 5.12B | 4.29B | 3.61B | 3.88B | 3.75B | 3.68B | 3.03B | 3.79B | 3.72B | 3.55B | 3.15B | 3.43B | 3.36B | 3.16B | 3.16B | 3.41B | 2.94B | 2.86B | 2.97B | 4.95B | 3.45B | 5.14B | 2.53B |
Cost of Revenue | 573.6M | 576.5M | 669.4M | 584.6M | 521.6M | 530.2M | 464.3M | 565.4M | 491.1M | 480.2M | 433.8M | 629.1M | 541.8M | 508M | 557M | 507M | 410.4M | 371.5M | 479.2M | 1.06B | 526.4M | 764.8M | 375.4M |
Gross Profit | 4.54B | 3.71B | 2.94B | 3.3B | 3.23B | 3.15B | 2.56B | 3.22B | 3.23B | 3.07B | 2.71B | 2.81B | 2.82B | 2.65B | 2.61B | 2.91B | 2.53B | 2.49B | 2.49B | 3.89B | 2.93B | 4.37B | 2.15B |
Operating Income | 2.05B | 1.42B | 642.9M | 879.9M | 1.03B | 1.08B | 591.7M | 990.2M | 1.18B | 1.07B | 751.4M | 1.05B | 1.21B | 1.02B | 1B | 1.32B | 1.22B | 1.31B | 1.29B | 2.64B | 1.85B | 3.35B | 1.11B |
Interest Income | 181.8M | 183.3M | 183.5M | 193.3M | 175.1M | 174.8M | 173.5M | 183.1M | 187.4M | 179.4M | 161.5M | 148.7M | 133.7M | 118.3M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 2.28B | 1.53B | 831.2M | 1.04B | 1.76B | 1.52B | 905M | 958.1M | 1.49B | 1.63B | 700.7M | 1.15B | 1.11B | 1.08B | 858M | 1.32B | 1.51B | 963.2M | 1.06B | 2.5B | 1.82B | 3.75B | 1.25B |
Net Income | 1.95B | 1.3B | 727.2M | 844.6M | 1.46B | 1.39B | 808.7M | 917.7M | 1.34B | 1.43B | 722M | 1.16B | 1.01B | 968.4M | 817.8M | 1.2B | 1.32B | 852.1M | 973.5M | 2.23B | 1.63B | 3.1B | 1.12B |
Selling & General & Admin | 677.8M | 662.1M | 647.7M | 775M | 657.8M | 634.2M | 633M | 792.2M | 714.4M | 758.8M | 689M | 704.4M | 640.5M | 652M | 601.1M | 657M | 529.1M | 476.3M | 450M | 559.6M | 445M | 414.7M | 405.6M |
Research & Development | 1.82B | 1.63B | 1.65B | 1.63B | 1.56B | 1.43B | 1.34B | 1.43B | 1.33B | 1.22B | 1.26B | 1.05B | 969.9M | 982.2M | 1B | 941.6M | 818.7M | 719.9M | 769.5M | 711.1M | 592.2M | 643.1M | 675.5M |
Other Expenses | n/a | n/a | n/a | 18.7M | -10M | n/a | n/a | 15.5M | 8M | 14.6M | 15.3M | -500K | -500K | -600K | -500K | -6.6M | -45.7M | -17.4M | -20.2M | -15.8M | 42M | -31.3M | -40.5M |
Operating Expenses | 2.49B | 2.29B | 2.29B | 2.42B | 2.21B | 2.07B | 1.97B | 2.23B | 2.05B | 2B | 1.96B | 1.75B | 1.61B | 1.63B | 1.6B | 1.59B | 1.3B | 1.18B | 1.2B | 1.25B | 1.08B | 1.03B | 1.04B |
Interest Expense | 10.6M | 11M | 12.9M | 12.2M | 19.3M | 3.6M | 8.7M | 10.5M | 13.8M | 14.8M | 16.1M | 18.3M | 17.8M | 18.9M | 18M | 17.4M | 15.3M | 13.1M | 13.6M | 14.1M | 14.2M | 14.4M | 14.6M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 3.07B | 2.87B | 2.96B | 3B | 2.73B | 2.6B | 2.44B | 2.8B | 2.54B | 2.48B | 2.39B | 2.38B | 2.15B | 2.14B | 2.16B | 2.1B | 1.71B | 1.55B | 1.68B | 2.31B | 1.61B | 1.79B | 1.42B |
Income Tax Expense | 335.4M | 230.9M | 104M | 199.1M | 303.3M | 127.1M | 96.3M | 40.4M | 152.4M | 195.8M | -21.3M | -12M | 103M | 114.5M | 40.2M | 127.6M | 194.1M | 111.1M | 87.6M | 274.4M | 184.4M | 653.9M | 137.8M |
Shares Outstanding (Basic) | 101.7M | 103.4M | 104M | 102.9M | 103.62M | 105.1M | 106.7M | 107.9M | 108.1M | 108.1M | 107.8M | 106.6M | 106.3M | 107M | 107.1M | 107M | 112.8M | 114M | 113.07M | 106.2M | 106.2M | 105M | 110.5M |
Shares Outstanding (Diluted) | 105.6M | 106.8M | 107.7M | 107.5M | 107.2M | 108.6M | 111.2M | 113.8M | 116.2M | 115.4M | 115.1M | 113.8M | 113.4M | 113.9M | 114M | 114M | 112.8M | 114M | 113.1M | 113.2M | 113.9M | 110.8M | 110.53M |
EPS (Basic) | 19.16 | 12.59 | 6.99 | 8.21 | 14.09 | 13.24 | 7.58 | 8.53 | 12.40 | 13.25 | 6.70 | 10.88 | 9.48 | 9.05 | 7.64 | 11.19 | 11.66 | 7.47 | 8.61 | 20.99 | 15.37 | 29.51 | 10.58 |
EPS (Diluted) | 18.45 | 12.20 | 6.75 | 7.86 | 13.62 | 12.81 | 7.27 | 8.06 | 11.54 | 12.41 | 6.27 | 10.19 | 8.89 | 8.50 | 7.17 | 10.50 | 11.66 | 7.47 | 8.61 | 19.69 | 14.33 | 27.97 | 10.09 |
EBITDA | 2.42B | 1.66B | 967.3M | 1.2B | 1.92B | 1.66B | 1.04B | 1.1B | 1.63B | 1.76B | 830.9M | 1.28B | 1.23B | 1.2B | 975.5M | 1.44B | 1.62B | 1.05B | 1.15B | 2.59B | 1.9B | 3.84B | 1.34B |
EBIT | 2.29B | 1.54B | 844.1M | 1.06B | 1.78B | 1.52B | 913.7M | 968.6M | 1.51B | 1.64B | 716.8M | 1.17B | 1.13B | 1.1B | 876M | 1.34B | 1.53B | 976.3M | 1.07B | 2.52B | 1.83B | 3.77B | 1.27B |
Depreciation & Amortization | 121M | 123.7M | 123.2M | 145M | 136.7M | 135.1M | 126.9M | 126.4M | 121.7M | 120.7M | 114.1M | 113M | 105.4M | 103.1M | 99.5M | 100.1M | 92.6M | 74.4M | 74.3M | 74.5M | 73.2M | 71.1M | 67.4M |
Add to Watchlist
Select watchlists to add or remove REGN